The laboratory diagnosis of common genital viral infections.

Journal of Family Planning and Reproductive Health Care 2004: 30(1) 11 Mosca L, Collins P, Herrington DM, et al. Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 2001; 104: 499–503. 12 Shumaker SA, Legault C, Rapp SR, et al Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women’s Health Initiative Memory Study: a randomized controlled study. JAMA 2003; 289: 2651–2662. 13 Weiderpass E, Adami HO, Baron JA. Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst 1999; 91: 1131–1137. 14 Sturdee DW, Ulrich LG, Barlow DH, et al. The endometrial response to sequential and continuous combined oestrogen–progestogen replacement therapy. Br J Obstet Gynaecol 2000; 197: 1392–1400. 15 Scarabin PY, Olger E, Plu-Bureau G. Differential association of oral and transdermal oestrogen replacement therapy with venous thromboembolism risk. Lancet 2003; 362: 428–432. 16 Chu MC, Rath KM, Huie J, Taylor HS. Elevated basal FSH in normal cycling women is associated with unfavourable lipid levels and increased cardiovascular risk. Hum Reprod 2003; 18: 1570–1573. 17 Stevenson J. Long term effects of hormone replacement therapy. Lancet 2003; 361(9353): 253–254. 18 Women’s Health Initiative (WHI) website. http://www.whi.org 19 HRT: update on the risk of breast cancer and long-term safety. Current Problems in Pharmacovigilance September 2003; 29: 1–3. http://www.mca.gov.uk 20 New product information for hormone replacement therapy. Current Problems in Pharmacovigilance April 2002; 28: 1–2. http:// www.mca.gov.uk 21 Pitkin J, Rees MCP, Gray S, et al. Managing the menopause. British Menopause Society Council consensus statement on hormone replacement therapy. J Br Menopause Soc 2003; 9(3): 129–131. 22 Panay N, Studd JWW. Progestogen intolerance and compliance with hormone replacement therapy in menopausal women. Hum Reprod Update 1997; 3: 159–171. 23 Lagro-Janssen T, Rosser W, Van Weel C. Breast cancer and hormone replacement therapy: up to general practice to pick up the pieces. Lancet 2003; 362: 414–415. Overview